Launching in 2025: Think You Don't Have the Data You Need? Think Again.

Secondary Research as a Competitive Advantage

Pharma launches in 2025 are a race against time. With regulatory hurdles, intense competition, and high patient/professional expectations, companies must navigate complex landscapes while ensuring a seamless market entry. The demand for faster go-to-market strategies has never been greater, and pharma leaders must find ways to accelerate decision-making and execution without compromising quality.

Secondary research plays a critical role in expediting launch processes by leveraging existing data to gain deep insights into the market, competitive landscape, and patient behavior. Rather than waiting for primary research results, secondary research enables pharma teams to quickly analyze trends, refine positioning, and optimize launch strategies in real time.

Unlocking Market Insights Efficiently

In today’s fast-paced environment, making decisions without data is not an option. Secondary market research empowers pharma brands to launch with confidence by:

• Maximizing available data: Utilizing industry reports, academic studies, regulatory filings, and competitor insights to build a comprehensive launch strategy.
• Enhancing efficiency: Pre-existing research cuts down the time required for market understanding, allowing for quicker pivots and informed decision-making.
• Aligning with market dynamics: Ensuring that launch efforts correspond with evolving industry trends, competitive shifts, and patient needs.

Strengthening Pharma Launches with Secondary Research

While primary research gathers firsthand data through surveys and interviews, secondary research taps into pre-existing resources, offering:

• Market trends analysis: Identifying early signals of change and positioning for future opportunities.
• Competitive intelligence: Understanding competitor strategies, entry points, and areas of differentiation.
• Regulatory landscape insights: Staying ahead of evolving policies and compliance requirements.
• HCP and patient behavior analysis: Refining messaging and engagement strategies based on real-world data.

Transforming Challenges into Competitive Advantages

• Accelerate Time to Market: Streamline decision-making and reduce delays by leveraging existing research.
• Improve Competitive Positioning: Differentiate effectively through competitor analysis.
• Optimize Launch Execution: Ensure precise targeting, better resource allocation, and efficient deployment of commercial efforts.
• Enhance Digital Engagement: Leverage real-world data to fine-tune digital marketing and HCP outreach.
• Ensure Cost Efficiency: Reduce reliance on costly and time-consuming primary research.

Conducting Effective Secondary Research

To maximize impact, teams should follow a few simple steps:

1. Define Objectives: Establish clear, SMART goals aligned with launch priorities.
2. Identify High-Value Data Sources: Focus on reputable sources such as:

3. Analyze & Interpret Data: Apply qualitative and quantitative methods to extract meaningful insights.

4. Translate Insights into Action: Use findings to drive go-to-market strategies, messaging, and launch execution.

Overcoming Common Challenges

Leveraging AI & Technology in Secondary Research

Technology is revolutionizing how secondary research supports launch strategies:

• AI-Powered Data Processing: Automates the collection and synthesis of large datasets, reducing manual workload and increasing accuracy.
• Predictive Analytics: Identifies emerging market trends, helping pharma teams stay ahead of the curve.
• Data Visualization Tools: Platforms like Tableau and Power BI turn complex data into clear, actionable insights.
• Automated Data Collection: Enables real-time monitoring of market trends, HCP engagement, and patient sentiment.

Actionable Insights for Launch Teams

By integrating secondary research into launch planning, pharma leaders can:

• Shorten time to market with data-driven decision-making.
• Ensure competitive readiness by tracking competitor movements.
• Enhance HCP and patient engagement through tailored messaging.
• Optimize resource allocation based on market intelligence.

Conclusion: Turning Challenges into Strengths

Secondary research is no longer optional—it’s essential for successfully launching in today’s fast-moving pharma landscape. The ability to analyze existing data, anticipate market shifts, and leverage technology-driven insights enables pharma brands to launch faster, smarter, and more effectively.

By adopting a strategic approach to secondary research, pharma companies can ensure that every decision is backed by solid data, reducing uncertainty and maximizing launch success.

Your launch challenges can be transformed into competitive advantages. Secondary research could be the key to making that happen.

For more information, contact:

Annik Larsen Director, Global Business Development

e: [email protected] w: frontera-group.com

Why Work With Frontera?

At Frontera, we:

• RESEARCH must go beyond data, providing actionable insights that reveal untapped opportunities to shape strategies that differentiate.
• CONSULTING must deliver bespoke solutions that not only address challenges but position you as a leader in patient care.
• CREATIVE must cut through the noise, via behavior-driving engagement, to achieve stand out and impact.

"Partnering with Frontera has been instrumental in ensuring our launch strategy is fully evidence-based. Their collaborative approach and deep expertise helped us navigate complex challenges (in short time frames) with confidence. Moreover, they supported me and my decision making, every step of the way." Global Asset Lead.

#PharmaLaunch #GoToMarket #SecondaryResearch #CompetitiveAdvantage #MarketInsights #PharmaStrategy #DataDrivenDecisions #AIinPharma #HealthcareInnovation #RegulatoryCompliance #PatientCentricity #HCPEngagement #MarketTrends #DigitalPharma #PharmaMarketing #BusinessIntelligence #PredictiveAnalytics #DataVisualization #PharmaSuccess #IndustryInsights